The Valley Desk

NCT00126503 · Interventional trial

Sorafenib Tosylate and Bevacizumab in Treating Patients With Advanced Kidney Cancer

Overall registry status Completed

Phase 1 · Phase 2

Conditions Chromophobe Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Recurrent Renal Cell Carcinoma, Sarcomatoid Renal Cell Carcinoma, Stage IV Renal Cell Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov